Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 0.45 is 109% above its 2-year average of 0.21, near the high end of its 2-year range (0.02–0.62).
As of the fiscal period ended Wednesday, December 31, 2025. 16.51% above its 12-month average of 0.38.
Reported quarterly current ratio; no daily interpolation. Q4 FY2025 (2025-12-31): 0.45.
CURRENT RATIO
0.45
CURRENT RATIO AVG TTM
0.38
CURRENT RATIO AVG 3Y
N/A
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+16.51%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-88.09%
vs the sector median at left
Jyong Biotech Ltd. Ordinary Shares
Market Cap
$152.82M
Current Ratio
0.45
TTM Avg
0.38
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$148.12M
Current Ratio
5.55
TTM Avg
4.34
3Y Avg
4.83
5Y Avg
5.46
Market Cap
$148.69M
Current Ratio
9.71
TTM Avg
4.67
3Y Avg
6.04
5Y Avg
19.74
Market Cap
$148.64M
Current Ratio
15.62
TTM Avg
10.23
3Y Avg
11.93
5Y Avg
11.24
Market Cap
$148.36M
Current Ratio
1.23
TTM Avg
1.14
3Y Avg
1.35
5Y Avg
4.96
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jyong Biotech Ltd. Ordinary Shares (MENS) | $152.82M | 0.45 | 0.38 | N/A | N/A |
| Neuronetics, Inc. (STIM)vs › | $153.91M | 1.88 | 1.94 | 2.90 | 3.95 |
| Veraxa Biotech Holding AG (VRXA)vs › | $149.89M | N/A | N/A | N/A | N/A |
| Cardiol Therapeutics Inc. (CRDL)vs › | $148.12M | 5.55 | 4.34 | 4.83 | 5.46 |
| Codexis, Inc. (CDXS)vs › | $148.97M | 3.06 | 4.00 | 3.48 | 4.36 |
| Inogen, Inc. (INGN)vs › | $156.90M | 2.74 | 2.77 | 3.26 | 3.97 |
| ALX Oncology Holdings Inc. (ALXO)vs › | $148.69M | 9.71 | 4.67 | 6.04 | 19.74 |
| Anavex Life Sciences Corp. (AVXL)vs › | $148.64M | 15.62 | 10.23 | 11.93 | 11.24 |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $148.36M | 1.23 | 1.14 | 1.35 | 4.96 |
| Voyager Therapeutics, Inc. (VYGR)vs › | $148.33M | 7.51 | 6.60 | 4.97 | 4.99 |
Current Ratio
0.45
Quick Ratio
0.45
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2025-12-31 | 0.45 |
| 2025-09-30 | 0.45 |
| 2025-06-30 | 0.62 |
| 2024-12-31 | 0.02 |
| 2024-09-30 | 0.02 |
| 2024-06-30 | 0.02 |
| 2024-03-31 | 0.02 |
| 2023-12-31 | 0.13 |
